🇺🇸 FDA

Company profile · Sponsor

Harmony

Harmony Biosciences Holdings

HRMY · NYSE pharma PLYMOUTH MEETING, PA, USA
Pipeline
21
Drugs
2
Patents
6

Quick answer

Harmony (HRMY) is a pharma company. headquartered in PLYMOUTH MEETING, PA, USA. listed on NYSE. NovaPharmaNews links 21 pipeline programs, 2 drugs, and 6 patents to this profile..

Company facts

Ticker HRMY
Exchange NYSE
Company type pharma
Headquarters PLYMOUTH MEETING, PA, USA
SEC CIK 0001802665

Pipeline (21)

Search pipeline →

  1. Clemizole HCl

    Harmony

    Lennox Gastaut Syndrome

    phase 3 small molecule active

    1 trial

  2. Clemizole HCl

    Harmony

    Dravet Syndrome

    phase 3 small molecule active

    1 trial

  3. HBS-101, White, round, plain, biconvex film-coated tablet. Matching 4.45 mg tablet is 3.7 mm in diameter., White, round, plain, biconvex film-coated tablet. matching 17.8 mg tablet is 7.5 mm in diameter., WAKIX, HBS-101, WAKIX

    Harmony

    Prader-Willi syndrome

    phase 3 small molecule active

    1 trial

  4. HBS-301 tablet

    Harmony

    Idiopathic Hypersomnia

    phase 3 small molecule active

    1 trial

  5. Open-label pitolisant

    Harmony

    Idiopathic Hypersomnia

    phase 3 small molecule completed

    1 trial

  6. Pitolisant

    Harmony

    Idiopathic Hypersomnia

    phase 3 small molecule completed

    1 trial

  7. Pitolisant

    Harmony

    Prader-Willi Syndrome

    phase 3 small molecule active

    1 trial

  8. Pitolisant tablet

    Harmony

    Prader-Willi Syndrome

    phase 3 small molecule active

    1 trial

  9. ZYN002 Transdermal Gel Cannabidiol (CBD)

    Harmony

    Fragile X Syndrome (FXS)

    phase 3 small molecule active

    1 trial

  10. ZYN002 Transdermal Gel Cannabidiol (CBD), ZYN002 Placebo Transdermal Gel

    Harmony

    Fragile X syndrome (FXS)

    phase 3 small molecule active

    1 trial

  11. OVX836 480µg

    Harmony

    Influenza

    phase 2 mab completed

    1 trial

  12. OVX836 shot

    Harmony

    Vaccine-Preventable Diseases

    phase 2 mab completed

    1 trial

  13. Pitolisant Oral Tablet

    Harmony

    Myotonic Dystrophy 1

    phase 2 small molecule completed

    1 trial

  14. Pitolisant oral tablets

    Harmony

    Prader-Willi Syndrome

    phase 2 small molecule completed

    1 trial

  15. ZYN002

    Harmony

    22Q11.2 Deletion Syndrome

    phase 2 small molecule completed

    1 trial

  16. HBS-201

    Harmony

    Narcolepsy

    phase 1 small molecule completed

    1 trial

  17. MV-LASV

    Harmony

    Lassa Virus Infection

    phase 1 mab completed

    1 trial

  18. Part 1

    Harmony

    Drug Interaction

    phase 1 small molecule completed

    1 trial

  19. Pitolisant

    Harmony

    Restless Legs Syndrome

    approved small molecule active

    1 trial

  20. Complex with Biotin 5,000 mcg, Collagen, Keratin and Hyaluronic Acid.

    Harmony

    Hair Thinning

    other active

    1 trial

  21. Complex with Biotin, Collagen, Keratin, Hyaluronic Acid.

    Harmony

    Hair Thinning

    other completed

    1 trial

Drugs (2)

Search drugs →

  1. calfactant

    INFASURF PRESERVATIVE FREE

    INTRATRACHEAL approved

  2. pitolisant hydrochloride

    WAKIX

    ORAL approved

Patents (6)

Search patents →

  1. US 12226373

    Treatment of fragile X syndrome with cannabidiol

    Expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12213951

    Treatment of autism with cannabidiol

    Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12186282

    Treatment of 22Q11.2 deletion syndrome with cannabidiol

    Expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9296774

    Halogenated dideoxy sugar derivates, preparation method and application thereof

    Expires Mon Mar 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7625575

    Dermatological composition

    Expires Mon Nov 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7582307

    Dermatological composition

    Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Harmony?

Harmony (HRMY) is a pharma company. headquartered in PLYMOUTH MEETING, PA, USA. listed on NYSE. NovaPharmaNews links 21 pipeline programs, 2 drugs, and 6 patents to this profile..

What pipeline programs does Harmony sponsor?

We track 21 ClinicalTrials.gov-linked programs for Harmony, including Clemizole HCl and 20 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Harmony company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.